title: Defining new surrogate markers for CKD progression.
abstract: At a recent meeting of international experts on clinical aspects of progressive chronic kidney disease (CKD), an extensive analysis of extant clinical trials was used to develop more effective and economical surrogate markers for CKD outcomes in adults. This article describes the reasons for this undertaking, the methods and conclusions of the meeting, and the relevance of these findings to pediatric nephrology.
authors.affiliation: Department of Pediatrics, Northwestern University Feinberg School of Medicine, Morton Building Room 4-685G, 320 E. Superior, Chicago, IL, 60611, USA, schnaper@northwestern.edu.
authors.forename: H William
authors.initials: HW
authors.lastname: Schnaper
authors.forename: Susan L
authors.initials: SL
authors.lastname: Furth
authors.forename: Lynne P
authors.initials: LP
authors.lastname: Yao
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000032:analysis*; D002648:Child; D018450:Disease Progression; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D008297:Male; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers